Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
Tucatinib with trastuzumab and capecitabine for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies (ID3828)

National Institute for Health Research · United Kingdom · £8.2M GBP

Grant Information

Provide details about the grant you are applying for


$
Applicant Information

Tell us about yourself and your organization


$
Proposal & Supporting Documents

Provide additional details and upload your proposal document


Accepted formats: PDF, DOC, DOCX. Max size: 10MB